| Statistics for the Plotted Points |
| BROMACIL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 4 | 114% | 14% | 110% | 14% |
| >= Reporting Level | 73 | 110% | 15% | 111% | 15% |
| Total | 77 | 111% | 15% | 111% | 14% |
| Miscellaneous Statistics for the Samples |
| BROMACIL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 77 | 100% | Spiked |
| Estimated Values | 28 | 36% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 77 | . | |
| False Negatives | 0 | 0% | 0 out of 77 |
| Not Spiked | 28 | . | |
| False Positives | 0 | 0% | 0 out of 28 |
| Statistics for the Plotted Points |
| CYCLOATE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 40 | 90% | 13% | 87% | 14% |
| Total | 40 | 90% | 13% | 87% | 14% |
| Miscellaneous Statistics for the Samples |
| CYCLOATE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 40 | 98% | Spiked |
| Estimated Values | 6 | 15% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 41 | . | |
| False Negatives | 1 | 2% | 1 out of 41 |
| Not Spiked | 64 | . | |
| False Positives | 0 | 0% | 0 out of 64 |
| Statistics for the Plotted Points |
| TERBACIL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 3 | 121% | 5% | 122% | 7% |
| >= Reporting Level | 40 | 120% | 17% | 120% | 17% |
| Total | 43 | 120% | 16% | 121% | 14% |
| Miscellaneous Statistics for the Samples |
| TERBACIL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 43 | 96% | Spiked |
| Estimated Values | 20 | 44% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 2% | Spiked |
| Spiked | 45 | . | |
| False Negatives | 1 | 2% | 1 out of 45 |
| Not Spiked | 60 | . | |
| False Positives | 0 | 0% | 0 out of 60 |
| Statistics for the Plotted Points |
| DIPHENAMID |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 29 | 106% | 10% | 106% | 7% |
| Total | 29 | 106% | 10% | 106% | 7% |
| Miscellaneous Statistics for the Samples |
| DIPHENAMID |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 29 | 100% | Spiked |
| Estimated Values | 0 | 0% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 29 | . | |
| False Negatives | 0 | 0% | 0 out of 29 |
| Not Spiked | 76 | . | |
| False Positives | 0 | 0% | 0 out of 76 |
| Statistics for the Plotted Points |
| DEISOPROPYLATRAZINE (2-CHLORO-6-ETHYLAMINO-4-AMINO-S-TRIAZINE) |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 7 | 105% | 50% | 124% | 59% |
| >= Reporting Level | 28 | 97% | 32% | 103% | 16% |
| Total | 35 | 98% | 36% | 106% | 24% |
| Miscellaneous Statistics for the Samples |
| DEISOPROPYLATRAZINE (2-CHLORO-6-ETHYLAMINO-4-AMINO-S-TRIAZINE) |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 35 | 97% | Spiked |
| Estimated Values | 28 | 78% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 3% | Spiked |
| Spiked | 36 | . | |
| False Negatives | 0 | 0% | 0 out of 36 |
| Not Spiked | 68 | . | |
| False Positives | 7 | 10% | 7 out of 68 |
| Statistics for the Plotted Points |
| DEETHYLDEISOPROPYLATRAZINE (CHLORODIAMINO-S-TRIAZINE) |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 1 | 41% | . | 41% | 0% |
| >= Reporting Level | 10 | 19% | 14% | 15% | 15% |
| Total | 11 | 21% | 14% | 16% | 20% |
| Miscellaneous Statistics for the Samples |
| DEETHYLDEISOPROPYLATRAZINE (CHLORODIAMINO-S-TRIAZINE) |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 11 | 35% | Spiked |
| Estimated Values | 8 | 26% | Spiked |
| Deleted Values | 1 | 1% | Spiked + Not Spiked |
| Spiked, Censored | 7 | 23% | Spiked |
| Spiked | 31 | . | |
| False Negatives | 13 | 42% | 13 out of 31 |
| Not Spiked | 73 | . | |
| False Positives | 0 | 0% | 0 out of 72 |
| Statistics for the Plotted Points |
| DEETHYLATRAZINE (DESETHYL ATRAZINE) (2-CHLORO-4-ISOPROPYLAMINO-6-S-TRIAZINE) |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 57 | 95% | 28% | 99% | 17% |
| Total | 57 | 95% | 28% | 99% | 17% |
| Miscellaneous Statistics for the Samples |
| DEETHYLATRAZINE (DESETHYL ATRAZINE) (2-CHLORO-4-ISOPROPYLAMINO-6-S-TRIAZINE) |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 57 | 100% | Spiked |
| Estimated Values | 10 | 18% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 57 | . | |
| False Negatives | 0 | 0% | 0 out of 57 |
| Not Spiked | 48 | . | |
| False Positives | 0 | 0% | 0 out of 48 |
| Statistics for the Plotted Points |
| DICAMBA |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 5 | 110% | 13% | 107% | 16% |
| >= Reporting Level | 53 | 108% | 24% | 110% | 18% |
| Total | 58 | 108% | 23% | 110% | 18% |
| Miscellaneous Statistics for the Samples |
| DICAMBA |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 58 | 89% | Spiked |
| Estimated Values | 13 | 20% | Spiked |
| Deleted Values | 1 | 1% | Spiked + Not Spiked |
| Spiked, Censored | 2 | 3% | Spiked |
| Spiked | 66 | . | |
| False Negatives | 5 | 8% | 5 out of 65 |
| Not Spiked | 39 | . | |
| False Positives | 0 | 0% | 0 out of 39 |
| Statistics for the Plotted Points |
| LINURON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 35 | 105% | 8% | 103% | 8% |
| Total | 35 | 105% | 8% | 103% | 8% |
| Miscellaneous Statistics for the Samples |
| LINURON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 35 | 100% | Spiked |
| Estimated Values | 1 | 3% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 35 | . | |
| False Negatives | 0 | 0% | 0 out of 35 |
| Not Spiked | 70 | . | |
| False Positives | 0 | 0% | 0 out of 70 |
| Statistics for the Plotted Points |
| MCPA |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 11 | 95% | 28% | 95% | 36% |
| >= Reporting Level | 40 | 99% | 35% | 96% | 23% |
| Total | 51 | 98% | 33% | 96% | 24% |
| Miscellaneous Statistics for the Samples |
| MCPA |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 51 | 89% | Spiked |
| Estimated Values | 29 | 51% | Spiked |
| Deleted Values | 4 | 4% | Spiked + Not Spiked |
| Spiked, Censored | 6 | 11% | Spiked |
| Spiked | 59 | . | |
| False Negatives | 0 | 0% | 0 out of 57 |
| Not Spiked | 46 | . | |
| False Positives | 0 | 0% | 0 out of 44 |
| Statistics for the Plotted Points |
| MCPB |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 3 | 87% | 48% | 81% | 71% |
| >= Reporting Level | 25 | 95% | 27% | 83% | 22% |
| Total | 28 | 94% | 28% | 83% | 27% |
| Miscellaneous Statistics for the Samples |
| MCPB |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 28 | 68% | Spiked |
| Estimated Values | 15 | 37% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 8 | 20% | Spiked |
| Spiked | 41 | . | |
| False Negatives | 5 | 12% | 5 out of 41 |
| Not Spiked | 64 | . | |
| False Positives | 0 | 0% | 0 out of 64 |
| Statistics for the Plotted Points |
| METHIOCARB |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 1 | 84% | . | 84% | 0% |
| >= Reporting Level | 34 | 65% | 36% | 69% | 43% |
| Total | 35 | 66% | 36% | 72% | 43% |
| Miscellaneous Statistics for the Samples |
| METHIOCARB |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 35 | 97% | Spiked |
| Estimated Values | 7 | 19% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 36 | . | |
| False Negatives | 1 | 3% | 1 out of 36 |
| Not Spiked | 69 | . | |
| False Positives | 0 | 0% | 0 out of 69 |
| Statistics for the Plotted Points |
| PROPOXUR |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 39 | 92% | 16% | 95% | 18% |
| Total | 39 | 92% | 16% | 95% | 18% |
| Miscellaneous Statistics for the Samples |
| PROPOXUR |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 39 | 98% | Spiked |
| Estimated Values | 1 | 3% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 40 | . | |
| False Negatives | 1 | 3% | 1 out of 40 |
| Not Spiked | 65 | . | |
| False Positives | 0 | 0% | 0 out of 65 |
| Statistics for the Plotted Points |
| SIDURON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 44 | 113% | 15% | 111% | 11% |
| Total | 44 | 113% | 15% | 111% | 11% |
| Miscellaneous Statistics for the Samples |
| SIDURON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 44 | 100% | Spiked |
| Estimated Values | 3 | 7% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 44 | . | |
| False Negatives | 0 | 0% | 0 out of 44 |
| Not Spiked | 61 | . | |
| False Positives | 0 | 0% | 0 out of 61 |
| Statistics for the Plotted Points |
| BENTAZON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 1 | 73% | . | 73% | 0% |
| >= Reporting Level | 60 | 78% | 25% | 78% | 18% |
| Total | 61 | 78% | 25% | 78% | 18% |
| Miscellaneous Statistics for the Samples |
| BENTAZON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 61 | 100% | Spiked |
| Estimated Values | 26 | 43% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 61 | . | |
| False Negatives | 0 | 0% | 0 out of 61 |
| Not Spiked | 44 | . | |
| False Positives | 0 | 0% | 0 out of 44 |
| Statistics for the Plotted Points |
| 2,4-DB |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 29 | 90% | 30% | 77% | 18% |
| Total | 29 | 90% | 30% | 77% | 18% |
| Miscellaneous Statistics for the Samples |
| 2,4-DB |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 29 | 100% | Spiked |
| Estimated Values | 9 | 31% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 29 | . | |
| False Negatives | 0 | 0% | 0 out of 29 |
| Not Spiked | 76 | . | |
| False Positives | 0 | 0% | 0 out of 76 |
| Statistics for the Plotted Points |
| FLUOMETURON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 62 | 106% | 16% | 106% | 13% |
| Total | 62 | 106% | 16% | 106% | 13% |
| Miscellaneous Statistics for the Samples |
| FLUOMETURON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 62 | 100% | Spiked |
| Estimated Values | 8 | 13% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 62 | . | |
| False Negatives | 0 | 0% | 0 out of 62 |
| Not Spiked | 43 | . | |
| False Positives | 0 | 0% | 0 out of 43 |
| Statistics for the Plotted Points |
| OXAMYL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 7 | 86% | 38% | 95% | 22% |
| >= Reporting Level | 29 | 78% | 32% | 84% | 22% |
| Total | 36 | 79% | 33% | 90% | 22% |
| Miscellaneous Statistics for the Samples |
| OXAMYL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 36 | 69% | Spiked |
| Estimated Values | 14 | 27% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 6 | 12% | Spiked |
| Spiked | 52 | . | |
| False Negatives | 10 | 19% | 10 out of 52 |
| Not Spiked | 53 | . | |
| False Positives | 0 | 0% | 0 out of 53 |
| Statistics for the Plotted Points |
| ATRAZINE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 49 | 109% | 26% | 112% | 21% |
| Total | 49 | 109% | 26% | 112% | 21% |
| Miscellaneous Statistics for the Samples |
| ATRAZINE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 49 | 100% | Spiked |
| Estimated Values | 6 | 12% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 49 | . | |
| False Negatives | 0 | 0% | 0 out of 49 |
| Not Spiked | 56 | . | |
| False Positives | 0 | 0% | 0 out of 56 |
| Statistics for the Plotted Points |
| 2,4-D |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 10 | 119% | 45% | 125% | 29% |
| >= Reporting Level | 70 | 94% | 37% | 96% | 29% |
| Total | 80 | 97% | 38% | 103% | 34% |
| Miscellaneous Statistics for the Samples |
| 2,4-D |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 80 | 95% | Spiked |
| Estimated Values | 16 | 19% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 2 | 2% | Spiked |
| Spiked | 84 | . | |
| False Negatives | 2 | 2% | 2 out of 84 |
| Not Spiked | 21 | . | |
| False Positives | 7 | 33% | 7 out of 21 |
| Statistics for the Plotted Points |
| TRICLOPYR |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 1 | 135% | . | 135% | 0% |
| >= Reporting Level | 65 | 112% | 34% | 112% | 34% |
| Total | 66 | 112% | 34% | 113% | 34% |
| Miscellaneous Statistics for the Samples |
| TRICLOPYR |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 66 | 100% | Spiked |
| Estimated Values | 19 | 29% | Spiked |
| Deleted Values | 3 | 3% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 68 | . | |
| False Negatives | 0 | 0% | 0 out of 66 |
| Not Spiked | 37 | . | |
| False Positives | 0 | 0% | 0 out of 36 |
| Statistics for the Plotted Points |
| PROPHAM |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 3 | 124% | 17% | 115% | 23% |
| >= Reporting Level | 29 | 104% | 14% | 109% | 13% |
| Total | 32 | 106% | 16% | 110% | 14% |
| Miscellaneous Statistics for the Samples |
| PROPHAM |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 32 | 91% | Spiked |
| Estimated Values | 4 | 11% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 2 | 6% | Spiked |
| Spiked | 35 | . | |
| False Negatives | 1 | 3% | 1 out of 35 |
| Not Spiked | 70 | . | |
| False Positives | 0 | 0% | 0 out of 70 |
| Statistics for the Plotted Points |
| PICLORAM |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 43 | 91% | 25% | 93% | 24% |
| Total | 43 | 91% | 25% | 93% | 24% |
| Miscellaneous Statistics for the Samples |
| PICLORAM |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 43 | 93% | Spiked |
| Estimated Values | 4 | 9% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 3 | 7% | Spiked |
| Spiked | 46 | . | |
| False Negatives | 0 | 0% | 0 out of 46 |
| Not Spiked | 59 | . | |
| False Positives | 0 | 0% | 0 out of 59 |
| Statistics for the Plotted Points |
| ORYZALIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 39 | 96% | 15% | 95% | 18% |
| Total | 39 | 96% | 15% | 95% | 18% |
| Miscellaneous Statistics for the Samples |
| ORYZALIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 39 | 98% | Spiked |
| Estimated Values | 1 | 3% | Spiked |
| Deleted Values | 1 | 1% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 3% | Spiked |
| Spiked | 40 | . | |
| False Negatives | 0 | 0% | 0 out of 40 |
| Not Spiked | 65 | . | |
| False Positives | 0 | 0% | 0 out of 64 |
| Statistics for the Plotted Points |
| NORFLURAZON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 47 | 110% | 14% | 111% | 16% |
| Total | 47 | 110% | 14% | 111% | 16% |
| Miscellaneous Statistics for the Samples |
| NORFLURAZON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 47 | 96% | Spiked |
| Estimated Values | 14 | 29% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 2% | Spiked |
| Spiked | 49 | . | |
| False Negatives | 1 | 2% | 1 out of 49 |
| Not Spiked | 56 | . | |
| False Positives | 0 | 0% | 0 out of 56 |
| Statistics for the Plotted Points |
| NEBURON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 40 | 101% | 11% | 102% | 11% |
| Total | 40 | 101% | 11% | 102% | 11% |
| Miscellaneous Statistics for the Samples |
| NEBURON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 40 | 100% | Spiked |
| Estimated Values | 5 | 13% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 40 | . | |
| False Negatives | 0 | 0% | 0 out of 40 |
| Not Spiked | 65 | . | |
| False Positives | 0 | 0% | 0 out of 65 |
| Statistics for the Plotted Points |
| METHOMYL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 5 | 108% | 10% | 104% | 10% |
| >= Reporting Level | 45 | 95% | 19% | 99% | 16% |
| Total | 50 | 96% | 19% | 100% | 16% |
| Miscellaneous Statistics for the Samples |
| METHOMYL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 50 | 96% | Spiked |
| Estimated Values | 40 | 77% | Spiked |
| Deleted Values | 1 | 1% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 2% | Spiked |
| Spiked | 52 | . | |
| False Negatives | 1 | 2% | 1 out of 52 |
| Not Spiked | 52 | . | |
| False Positives | 0 | 0% | 0 out of 51 |
| Statistics for the Plotted Points |
| FENURON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 2 | 121% | 31% | 121% | 33% |
| >= Reporting Level | 29 | 107% | 10% | 107% | 9% |
| Total | 31 | 108% | 12% | 107% | 11% |
| Miscellaneous Statistics for the Samples |
| FENURON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 31 | 89% | Spiked |
| Estimated Values | 2 | 6% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 3 | 9% | Spiked |
| Spiked | 35 | . | |
| False Negatives | 1 | 3% | 1 out of 35 |
| Not Spiked | 70 | . | |
| False Positives | 0 | 0% | 0 out of 70 |
| Statistics for the Plotted Points |
| DIURON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 55 | 103% | 15% | 106% | 14% |
| Total | 55 | 103% | 15% | 106% | 14% |
| Miscellaneous Statistics for the Samples |
| DIURON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 55 | 100% | Spiked |
| Estimated Values | 6 | 11% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 55 | . | |
| False Negatives | 0 | 0% | 0 out of 55 |
| Not Spiked | 50 | . | |
| False Positives | 0 | 0% | 0 out of 50 |
| Statistics for the Plotted Points |
| DINOSEB |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 6 | 110% | 14% | 105% | 17% |
| >= Reporting Level | 48 | 95% | 26% | 94% | 32% |
| Total | 54 | 97% | 26% | 98% | 31% |
| Miscellaneous Statistics for the Samples |
| DINOSEB |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 54 | 98% | Spiked |
| Estimated Values | 17 | 31% | Spiked |
| Deleted Values | 1 | 1% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 55 | . | |
| False Negatives | 1 | 2% | 1 out of 55 |
| Not Spiked | 50 | . | |
| False Positives | 0 | 0% | 0 out of 49 |
| Statistics for the Plotted Points |
| DICHLOROPROP (DICHLORPROP) |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 46 | 100% | 27% | 96% | 26% |
| Total | 46 | 100% | 27% | 96% | 26% |
| Miscellaneous Statistics for the Samples |
| DICHLOROPROP (DICHLORPROP) |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 46 | 96% | Spiked |
| Estimated Values | 5 | 10% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 48 | . | |
| False Negatives | 2 | 4% | 2 out of 48 |
| Not Spiked | 57 | . | |
| False Positives | 0 | 0% | 0 out of 57 |
| Statistics for the Plotted Points |
| DACTHAL MONOACID |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 7 | 125% | 20% | 132% | 21% |
| >= Reporting Level | 27 | 104% | 29% | 99% | 41% |
| Total | 34 | 109% | 29% | 111% | 39% |
| Miscellaneous Statistics for the Samples |
| DACTHAL MONOACID |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 34 | 97% | Spiked |
| Estimated Values | 14 | 40% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 35 | . | |
| False Negatives | 1 | 3% | 1 out of 35 |
| Not Spiked | 70 | . | |
| False Positives | 1 | 1% | 1 out of 70 |
| Statistics for the Plotted Points |
| CLOPYRALID |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 3 | 60% | 17% | 58% | 25% |
| >= Reporting Level | 27 | 55% | 19% | 57% | 18% |
| Total | 30 | 55% | 18% | 58% | 16% |
| Miscellaneous Statistics for the Samples |
| CLOPYRALID |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 30 | 88% | Spiked |
| Estimated Values | 22 | 65% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 2 | 6% | Spiked |
| Spiked | 34 | . | |
| False Negatives | 2 | 6% | 2 out of 34 |
| Not Spiked | 70 | . | |
| False Positives | 0 | 0% | 0 out of 70 |
| Statistics for the Plotted Points |
| CHLOROTHALONIL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 1 | 15% | . | 15% | 0% |
| Total | 1 | 15% | . | 15% | 0% |
| Miscellaneous Statistics for the Samples |
| CHLOROTHALONIL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 1 | 5% | Spiked |
| Estimated Values | 1 | 5% | Spiked |
| Deleted Values | 3 | 5% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 21 | . | |
| False Negatives | 19 | 95% | 19 out of 20 |
| Not Spiked | 38 | . | |
| False Positives | 0 | 0% | 0 out of 36 |
| Statistics for the Plotted Points |
| 3-HYDROXYCARBOFURAN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 28 | 80% | 36% | 92% | 36% |
| Total | 28 | 80% | 36% | 92% | 36% |
| Miscellaneous Statistics for the Samples |
| 3-HYDROXYCARBOFURAN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 28 | 100% | Spiked |
| Estimated Values | 4 | 14% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 28 | . | |
| False Negatives | 0 | 0% | 0 out of 28 |
| Not Spiked | 77 | . | |
| False Positives | 1 | 1% | 1 out of 77 |
| Statistics for the Plotted Points |
| CARBOFURAN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 2 | 76% | 14% | 76% | 15% |
| >= Reporting Level | 43 | 91% | 20% | 93% | 21% |
| Total | 45 | 90% | 20% | 91% | 20% |
| Miscellaneous Statistics for the Samples |
| CARBOFURAN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 45 | 100% | Spiked |
| Estimated Values | 5 | 11% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 45 | . | |
| False Negatives | 0 | 0% | 0 out of 45 |
| Not Spiked | 60 | . | |
| False Positives | 0 | 0% | 0 out of 60 |
| Statistics for the Plotted Points |
| CARBARYL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 50 | 73% | 35% | 92% | 43% |
| Total | 50 | 73% | 35% | 92% | 43% |
| Miscellaneous Statistics for the Samples |
| CARBARYL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 50 | 96% | Spiked |
| Estimated Values | 7 | 13% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 52 | . | |
| False Negatives | 2 | 4% | 2 out of 52 |
| Not Spiked | 53 | . | |
| False Positives | 0 | 0% | 0 out of 53 |
| Statistics for the Plotted Points |
| BROMOXYNIL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 1 | 67% | . | 67% | 0% |
| >= Reporting Level | 32 | 78% | 25% | 82% | 22% |
| Total | 33 | 78% | 25% | 81% | 21% |
| Miscellaneous Statistics for the Samples |
| BROMOXYNIL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 33 | 94% | Spiked |
| Estimated Values | 6 | 17% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 3% | Spiked |
| Spiked | 35 | . | |
| False Negatives | 1 | 3% | 1 out of 35 |
| Not Spiked | 70 | . | |
| False Positives | 0 | 0% | 0 out of 70 |
| Statistics for the Plotted Points |
| ALDICARB |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 2 | 40% | 23% | 40% | 24% |
| >= Reporting Level | 24 | 64% | 19% | 70% | 15% |
| Total | 26 | 62% | 20% | 68% | 16% |
| Miscellaneous Statistics for the Samples |
| ALDICARB |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 26 | 57% | Spiked |
| Estimated Values | 26 | 57% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 17 | 37% | Spiked |
| Spiked | 46 | . | |
| False Negatives | 3 | 7% | 3 out of 46 |
| Not Spiked | 59 | . | |
| False Positives | 0 | 0% | 0 out of 59 |
| Statistics for the Plotted Points |
| ALDICARB SULFONE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 34 | 84% | 16% | 84% | 19% |
| Total | 34 | 84% | 16% | 84% | 19% |
| Miscellaneous Statistics for the Samples |
| ALDICARB SULFONE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 34 | 100% | Spiked |
| Estimated Values | 9 | 26% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 34 | . | |
| False Negatives | 0 | 0% | 0 out of 34 |
| Not Spiked | 71 | . | |
| False Positives | 15 | 21% | 15 out of 71 |
| Statistics for the Plotted Points |
| ALDICARB SULFOXIDE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 8 | 99% | 17% | 99% | 15% |
| >= Reporting Level | 38 | 76% | 30% | 82% | 29% |
| Total | 46 | 80% | 30% | 85% | 24% |
| Miscellaneous Statistics for the Samples |
| ALDICARB SULFOXIDE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 46 | 94% | Spiked |
| Estimated Values | 30 | 61% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 3 | 6% | Spiked |
| Spiked | 49 | . | |
| False Negatives | 0 | 0% | 0 out of 49 |
| Not Spiked | 55 | . | |
| False Positives | 11 | 20% | 11 out of 55 |
| Statistics for the Plotted Points |
| ACIFLUORFEN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 2 | 107% | 29% | 107% | 31% |
| >= Reporting Level | 33 | 109% | 35% | 107% | 41% |
| Total | 35 | 109% | 35% | 107% | 41% |
| Miscellaneous Statistics for the Samples |
| ACIFLUORFEN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 35 | 100% | Spiked |
| Estimated Values | 12 | 34% | Spiked |
| Deleted Values | 1 | 1% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 36 | . | |
| False Negatives | 0 | 0% | 0 out of 35 |
| Not Spiked | 69 | . | |
| False Positives | 0 | 0% | 0 out of 69 |
| Statistics for the Plotted Points |
| 3-KETOCARBOFURAN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 3 | 35% | 30% | 44% | 43% |
| Total | 3 | 35% | 30% | 44% | 43% |
| Miscellaneous Statistics for the Samples |
| 3-KETOCARBOFURAN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 3 | 21% | Spiked |
| Estimated Values | 3 | 21% | Spiked |
| Deleted Values | 5 | 8% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 16 | . | |
| False Negatives | 11 | 79% | 11 out of 14 |
| Not Spiked | 43 | . | |
| False Positives | 0 | 0% | 0 out of 40 |
| Statistics for the Plotted Points |
| BENDIOCARB |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 7 | 78% | 21% | 77% | 12% |
| >= Reporting Level | 15 | 74% | 39% | 92% | 48% |
| Total | 22 | 75% | 34% | 83% | 21% |
| Miscellaneous Statistics for the Samples |
| BENDIOCARB |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 22 | 65% | Spiked |
| Estimated Values | 10 | 29% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 4 | 12% | Spiked |
| Spiked | 34 | . | |
| False Negatives | 8 | 24% | 8 out of 34 |
| Not Spiked | 71 | . | |
| False Positives | 0 | 0% | 0 out of 71 |
| Statistics for the Plotted Points |
| BENOMYL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 57 | 107% | 16% | 106% | 16% |
| Total | 57 | 107% | 16% | 106% | 16% |
| Miscellaneous Statistics for the Samples |
| BENOMYL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 57 | 100% | Spiked |
| Estimated Values | 8 | 14% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 57 | . | |
| False Negatives | 0 | 0% | 0 out of 57 |
| Not Spiked | 48 | . | |
| False Positives | 0 | 0% | 0 out of 48 |
| Statistics for the Plotted Points |
| CAFFEINE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 2 | 111% | 4% | 111% | 4% |
| >= Reporting Level | 45 | 119% | 31% | 120% | 28% |
| Total | 47 | 119% | 30% | 116% | 28% |
| Miscellaneous Statistics for the Samples |
| CAFFEINE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 47 | 98% | Spiked |
| Estimated Values | 8 | 17% | Spiked |
| Deleted Values | 1 | 1% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 2% | Spiked |
| Spiked | 49 | . | |
| False Negatives | 0 | 0% | 0 out of 48 |
| Not Spiked | 56 | . | |
| False Positives | 0 | 0% | 0 out of 56 |
| Statistics for the Plotted Points |
| CHLORIMURON ETHYL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 1 | 36% | . | 36% | 0% |
| >= Reporting Level | 29 | 53% | 54% | 19% | 59% |
| Total | 30 | 52% | 53% | 21% | 59% |
| Miscellaneous Statistics for the Samples |
| CHLORIMURON ETHYL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 30 | 47% | Spiked |
| Estimated Values | 24 | 38% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 4 | 6% | Spiked |
| Spiked | 64 | . | |
| False Negatives | 30 | 47% | 30 out of 64 |
| Not Spiked | 41 | . | |
| False Positives | 0 | 0% | 0 out of 41 |
| Statistics for the Plotted Points |
| SULFOMETURON METHYL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 5 | 84% | 54% | 53% | 74% |
| >= Reporting Level | 22 | 71% | 54% | 49% | 49% |
| Total | 27 | 73% | 53% | 51% | 54% |
| Miscellaneous Statistics for the Samples |
| SULFOMETURON METHYL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 27 | 53% | Spiked |
| Estimated Values | 9 | 18% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 7 | 14% | Spiked |
| Spiked | 51 | . | |
| False Negatives | 17 | 33% | 17 out of 51 |
| Not Spiked | 54 | . | |
| False Positives | 0 | 0% | 0 out of 54 |
| Statistics for the Plotted Points |
| 2-HYDROXYATRAZINE |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 5 | 119% | 10% | 119% | 11% |
| >= Reporting Level | 32 | 89% | 53% | 103% | 77% |
| Total | 37 | 93% | 50% | 110% | 70% |
| Miscellaneous Statistics for the Samples |
| 2-HYDROXYATRAZINE |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 37 | 95% | Spiked |
| Estimated Values | 24 | 62% | Spiked |
| Deleted Values | 7 | 7% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 3% | Spiked |
| Spiked | 40 | . | |
| False Negatives | 1 | 3% | 1 out of 39 |
| Not Spiked | 65 | . | |
| False Positives | 5 | 8% | 5 out of 59 |
| Statistics for the Plotted Points |
| IMAZAQUIN |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 4 | 152% | 14% | 157% | 14% |
| >= Reporting Level | 46 | 139% | 38% | 132% | 36% |
| Total | 50 | 140% | 37% | 136% | 32% |
| Miscellaneous Statistics for the Samples |
| IMAZAQUIN |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 50 | 100% | Spiked |
| Estimated Values | 50 | 100% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 50 | . | |
| False Negatives | 0 | 0% | 0 out of 50 |
| Not Spiked | 55 | . | |
| False Positives | 0 | 0% | 0 out of 55 |
| Statistics for the Plotted Points |
| METALAXYL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 2 | 100% | 6% | 100% | 6% |
| >= Reporting Level | 38 | 100% | 12% | 102% | 13% |
| Total | 40 | 100% | 12% | 102% | 12% |
| Miscellaneous Statistics for the Samples |
| METALAXYL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 40 | 100% | Spiked |
| Estimated Values | 6 | 15% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 40 | . | |
| False Negatives | 0 | 0% | 0 out of 40 |
| Not Spiked | 65 | . | |
| False Positives | 1 | 2% | 1 out of 65 |
| Statistics for the Plotted Points |
| NICOSULFURON |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 2 | 81% | 19% | 81% | 20% |
| >= Reporting Level | 24 | 90% | 87% | 51% | 108% |
| Total | 26 | 90% | 84% | 62% | 108% |
| Miscellaneous Statistics for the Samples |
| NICOSULFURON |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 26 | 65% | Spiked |
| Estimated Values | 15 | 38% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 3 | 8% | Spiked |
| Spiked | 40 | . | |
| False Negatives | 11 | 28% | 11 out of 40 |
| Not Spiked | 64 | . | |
| False Positives | 0 | 0% | 0 out of 64 |
| Statistics for the Plotted Points |
| IMAZETHAPYR |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 2 | 118% | 3% | 118% | 4% |
| >= Reporting Level | 31 | 127% | 31% | 126% | 33% |
| Total | 33 | 126% | 30% | 121% | 31% |
| Miscellaneous Statistics for the Samples |
| IMAZETHAPYR |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 33 | 97% | Spiked |
| Estimated Values | 10 | 29% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 3% | Spiked |
| Spiked | 34 | . | |
| False Negatives | 0 | 0% | 0 out of 34 |
| Not Spiked | 71 | . | |
| False Positives | 0 | 0% | 0 out of 71 |
| Statistics for the Plotted Points |
| 2,4-D METHYL ESTER |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 12 | 89% | 26% | 85% | 20% |
| >= Reporting Level | 31 | 62% | 28% | 61% | 25% |
| Total | 43 | 70% | 30% | 73% | 29% |
| Miscellaneous Statistics for the Samples |
| 2,4-D METHYL ESTER |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 43 | 70% | Spiked |
| Estimated Values | 14 | 23% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 8 | 13% | Spiked |
| Spiked | 61 | . | |
| False Negatives | 10 | 16% | 10 out of 61 |
| Not Spiked | 44 | . | |
| False Positives | 19 | 43% | 19 out of 44 |
| Statistics for the Plotted Points |
| PROPICONAZOLE (TILT) |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 55 | 102% | 11% | 100% | 9% |
| Total | 55 | 102% | 11% | 100% | 9% |
| Miscellaneous Statistics for the Samples |
| PROPICONAZOLE (TILT) |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 55 | 98% | Spiked |
| Estimated Values | 4 | 7% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 56 | . | |
| False Negatives | 1 | 2% | 1 out of 56 |
| Not Spiked | 49 | . | |
| False Positives | 0 | 0% | 0 out of 49 |
| Miscellaneous Statistics for the Samples |
| TRIBENURON-METHYL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 0 | . | Spiked |
| Estimated Values | 0 | . | Spiked |
| Deleted Values | 35 | 100% | Spiked + Not Spiked |
| Spiked, Censored | 0 | . | Spiked |
| Spiked | 4 | . | |
| False Negatives | 0 | . | 0 out of 0 |
| Not Spiked | 31 | . | |
| False Positives | 0 | . | 0 out of 0 |
| Statistics for the Plotted Points |
| CHLORAMBEN, METHYL ESTER |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 34 | 98% | 17% | 97% | 10% |
| Total | 34 | 98% | 17% | 97% | 10% |
| Miscellaneous Statistics for the Samples |
| CHLORAMBEN, METHYL ESTER |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 34 | 81% | Spiked |
| Estimated Values | 4 | 10% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 3 | 7% | Spiked |
| Spiked | 42 | . | |
| False Negatives | 5 | 12% | 5 out of 42 |
| Not Spiked | 63 | . | |
| False Positives | 0 | 0% | 0 out of 63 |
| Statistics for the Plotted Points |
| 3(4-CHLOROPHENYL) METHYL UREA |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 4 | 112% | 52% | 115% | 59% |
| >= Reporting Level | 28 | 111% | 26% | 107% | 27% |
| Total | 32 | 111% | 29% | 107% | 28% |
| Miscellaneous Statistics for the Samples |
| 3(4-CHLOROPHENYL) METHYL UREA |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 32 | 97% | Spiked |
| Estimated Values | 3 | 9% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 33 | . | |
| False Negatives | 1 | 3% | 1 out of 33 |
| Not Spiked | 72 | . | |
| False Positives | 0 | 0% | 0 out of 72 |
| Statistics for the Plotted Points |
| BENSULFURON-METHYL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 4 | 59% | 3% | 58% | 2% |
| >= Reporting Level | 40 | 67% | 48% | 60% | 69% |
| Total | 44 | 67% | 46% | 58% | 67% |
| Miscellaneous Statistics for the Samples |
| BENSULFURON-METHYL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 44 | 100% | Spiked |
| Estimated Values | 11 | 25% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 44 | . | |
| False Negatives | 0 | 0% | 0 out of 44 |
| Not Spiked | 61 | . | |
| False Positives | 0 | 0% | 0 out of 61 |
| Statistics for the Plotted Points |
| FLUMETSULAM |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 2 | 135% | 15% | 135% | 15% |
| >= Reporting Level | 30 | 133% | 33% | 130% | 34% |
| Total | 32 | 133% | 32% | 130% | 32% |
| Miscellaneous Statistics for the Samples |
| FLUMETSULAM |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 32 | 94% | Spiked |
| Estimated Values | 9 | 26% | Spiked |
| Deleted Values | 1 | 1% | Spiked + Not Spiked |
| Spiked, Censored | 1 | 3% | Spiked |
| Spiked | 34 | . | |
| False Negatives | 1 | 3% | 1 out of 34 |
| Not Spiked | 71 | . | |
| False Positives | 2 | 3% | 2 out of 70 |
| Statistics for the Plotted Points |
| IMIDACLOPRID |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| >= Reporting Level | 70 | 124% | 31% | 120% | 21% |
| Total | 70 | 124% | 31% | 120% | 21% |
| Miscellaneous Statistics for the Samples |
| IMIDACLOPRID |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 70 | 99% | Spiked |
| Estimated Values | 3 | 4% | Spiked |
| Deleted Values | 0 | 0% | Spiked + Not Spiked |
| Spiked, Censored | 0 | 0% | Spiked |
| Spiked | 71 | . | |
| False Negatives | 1 | 1% | 1 out of 71 |
| Not Spiked | 34 | . | |
| False Positives | 0 | 0% | 0 out of 34 |
| Statistics for the Plotted Points |
| METSULFURON METHYL |
| Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
|---|---|---|---|---|---|
| < Reporting Level | 2 | 101% | 10% | 101% | 11% |
| >= Reporting Level | 27 | 53% | 39% | 56% | 37% |
| Total | 29 | 56% | 40% | 57% | 41% |
| Miscellaneous Statistics for the Samples |
| METSULFURON METHYL |
| Characteristic | N | % | % Basis |
|---|---|---|---|
| Plotted | 29 | 74% | Spiked |
| Estimated Values | 29 | 74% | Spiked |
| Deleted Values | 1 | 1% | Spiked + Not Spiked |
| Spiked, Censored | 4 | 10% | Spiked |
| Spiked | 39 | . | |
| False Negatives | 6 | 15% | 6 out of 39 |
| Not Spiked | 66 | . | |
| False Positives | 1 | 2% | 1 out of 65 |